Clinical Trial Update: Wearable Activity Tracking to Curb Hospitalizations

View source ↗

Summary

An ongoing UCSF clinical trial is evaluating whether wearable activity tracking can reduce hospitalizations in patients with hematologic malignancies and solid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Lymphoma
• Solid Malignant Neoplasm

Snippet

Sponsor: University of California, San Francisco | Conditions: Hematopoietic Neoplasm, Malignant Solid Neoplasm | Status: RECRUITING